PFE Financial Facts
Diluted (in shares): 6.14BResearch and development expenses: 1.88B
See Full Income Statement
Accrued compensation and related items: 2.05B
Goodwill: 56.28B
See Full Balance Sheet
Pfizer Inc. (PFE) Earnings
|
Expand Research on PFE
| Next EPS Date | 8/4/26 | EPS Growth Rate | -12.8% |
|---|---|---|---|
| Average EPS % Beat Rate | +21.7% | Revenue Growth Rate | -1.8% |
| Average % Move 1-Wk after EPS | +0.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/4/26  |
Q226 | N/A | $0.68 | N/A | N/A | $14.44B | = | N/A | N/A | ||
| 5/5/26 | Q126 | $0.75 | $0.72 | +$0.03 | $14.5B | $13.84B | = |  | | Details | |
| 2/3/26 | Q425 | $0.66 | $0.58 | +$0.08 | $17.58B | $16.91B | = | | | Details | |
| 11/4/25 | Q325 | $0.87 | $0.66 | +$0.21 | $16.7B | $16.8B | = | | | Details | |
| 8/5/25 | Q225 | $0.78 | $0.57 | +$0.21 | $14.7B | $13.47B | = | | | Details | |
| 4/29/25 | Q125 | $0.92 | $0.68 | +$0.24 | $13.72B | $14.09B | = | | | Details | |
| 2/4/25 | Q424 | $0.63 | $0.48 | +$0.15 | $17.8B | $17.28B | = | | | Details | |
| 10/29/24 | Q324 | $1.06 | $0.62 | +$0.44 | $17.7B | $14.92B | = | | | Details |
